SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005800
Filing Date
2020-05-07
Accepted
2020-05-07 17:30:43
Documents
48
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20200331x10q.htm 10-Q 1242902
2 EX-31.1 nxtc-20200331ex311d75b05.htm EX-31.1 13469
3 EX-31.2 nxtc-20200331ex312aa71f5.htm EX-31.2 12390
4 EX-32.1 nxtc-20200331ex321d9fc93.htm EX-32.1 13683
  Complete submission text file 0001558370-20-005800.txt   4485751

Data Files

Seq Description Document Type Size
5 EX-101.INS nxtc-20200331.xml EX-101.INS 977228
6 EX-101.SCH nxtc-20200331.xsd EX-101.SCH 26359
7 EX-101.CAL nxtc-20200331_cal.xml EX-101.CAL 35049
8 EX-101.DEF nxtc-20200331_def.xml EX-101.DEF 97239
9 EX-101.LAB nxtc-20200331_lab.xml EX-101.LAB 293804
10 EX-101.PRE nxtc-20200331_pre.xml EX-101.PRE 199355
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 20857804
SIC: 2834 Pharmaceutical Preparations